Elizabeth Murphy Lilly - 31 Dec 2025 Form 4 Insider Report for APOGEE ENTERPRISES, INC. (APOG)

Role
Director
Signature
/s/ Meghan M. Elliott, Attorney-in-Fact for Elizabeth Murphy Lilly
Issuer symbol
APOG
Transactions as of
31 Dec 2025
Net transactions value
$0
Form type
4
Filing time
05 Jan 2026, 16:24:10 UTC
Previous filing
02 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Lilly Elizabeth Murphy Director C/O APOGEE ENTERPRISES, INC., 4400 WEST 78TH STREET, SUITE 520, MINNEAPOLIS /s/ Meghan M. Elliott, Attorney-in-Fact for Elizabeth Murphy Lilly 05 Jan 2026 0001799209

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APOG Deferred Restricted Stock Units Award $0 0 0% $36.41 6,845 31 Dec 2025 Common Stock 49 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The deferred restricted stock units were allocated under the 2019 Non-Employee Director Stock Plan. The deferred restricted stock units will be settled in shares of common stock following the director's termination from the Board in accordance with the election of the reporting person or following the occurrence of other events specified in the Plan.
F2 Settled 1-for-1.
F3 Additional deferred restricted stock units were allocated pursuant to a dividend equivalent reinvestment feature of the 2019 Non-Employee Director Stock Plan.